EUCTR2014-000973-38-DE进行中（未招募）1 期
Xenon-inhalation: elimination of xenon and its effect on erythropoetin-levels in blood of healthy volunteers - XEPO
RWTH Aachen vertreten durch das CTC-A0 个研究点目标入组 144 人开始时间: 2014年3月31日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Male subjects, age >18 years, legally competent to sign, without any known medical condition or medication prescribed at the Uniklinik RWTH Aachen
- •Persons that are able and willing to understand and follow the instructions of the study personnel.
- •Signed informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 144
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Smoker, alcoholic or person who regularly consumes drugs or medication.
- •Persons with a medical condition that is contraindicated with the planned treatment.
- •Known hypersensivity against xenon.
- •Persons not legally competent to sign.
- •Simultaneous participation at any other trial.
- •Blood-loss due to trauma during the period of the study or 2 months previous.
- •Blood donation during the period of the study or 2 months previous.
研究者
相似试验
终止
3 期
Influence on Erythropoetin-level by XenonHealthy VolunteersNCT02129400RWTH Aachen University36
进行中（未招募）
不适用
Effect of Xenon, in Combination with Therapeutic Hypothermia, on the Brain and on Neurological Outcome following Brain Ischemia in Cardiac Arrest PatientsSydänpysähdyksen jälkeinen globaali iskemiaMedDRA version: 9.1Level: LLTClassification code 10054438Term: IschemiaMedDRA version: 9.1Level: LLTClassification code 10007515Term: Cardiac arrestEUCTR2009-009505-25-FITimo Laitio
进行中（未招募）
不适用
The safety and feasibility of delivering xenon to patients before and after coronary artery bypass graft implantation: a pilot studyAbbreviated study title:A pre- and post-Coronary Artery bypass graft implantation Disposed Application of Xenon – CArDiAX - CArDiAXThe aim of this study is to determine whether xenon and remifentanil – as compared to sevoflurane and remifentanil – can be applied safely in patients after CABG implantation for the remaining surgery time.MedDRA version: 12.1Level: LLTClassification code 10002323Term: Anesthesia generalEUCTR2010-023942-63-DEClinical Trials Center Aachen, University of Aachen
进行中（未招募）
不适用
The safety and feasibility of administering Xenon-gas (anesthesia) to patients who are undergoing an off-pump (heart keeps beating on its own) bypass of the coronary artery XOPCAB stands for: Xenon in Off-Pump Coronary Artery Bypass GraftingEUCTR2012-002316-12-BEniversity Hospitals of the KU Leuven
进行中（未招募）
不适用
Xenon and Therapeutical Hypothermia After Successful CardiopulmonaryResuscitatioIn this clinical trial will be checked, whether 2 hours ventilation with xenon has neuroprotetctive effect on the patients, which had out of hospital cardiac arrest and successful cardiopulmonary resuscitationMedDRA version: 16.1Level: PTClassification code 10067221Term: Mechanical ventilationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-022679-71-DEClinical Trials Center Aachen, University of Aachen